BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21070957)

  • 1. Opioid-mediated drug actions cannot be concluded from naloxone induced reversal of anti-nociceptive effects in behavioural tests only.
    Lötsch J; Tegeder I
    Eur J Pain; 2010 Nov; 14(10):981-4. PubMed ID: 21070957
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of opioids in the formalin test in the Speke's hinged tortoise (Kinixy's spekii).
    Wambugu SN; Towett PK; Kiama SG; Abelson KS; Kanui TI
    J Vet Pharmacol Ther; 2010 Aug; 33(4):347-51. PubMed ID: 20646195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in opioid-mediated pain inhibitory mechanisms during the interphase in the formalin test.
    Gaumond I; Spooner MF; Marchand S
    Neuroscience; 2007 Apr; 146(1):366-74. PubMed ID: 17306464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
    Zhao M; Wang JY; Jia H; Tang JS
    Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone induces a bidirectional effect on phasic and "spontaneous" pain-related behaviour in rats with a peripheral mononeuropathy.
    Jazat F; Attal N; Kayser V; Guilbaud G
    Prog Clin Biol Res; 1990; 328():453-6. PubMed ID: 2154804
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists.
    Hartmann RJ; Geller I
    Proc West Pharmacol Soc; 1976; 19():243-7. PubMed ID: 11501
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
    Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T
    Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice.
    Boban Blagaic A; Turcic P; Blagaic V; Dubovecak M; Jelovac N; Zemba M; Radic B; Becejac T; Stancic Rokotov D; Sikiric P
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():177-81. PubMed ID: 20388962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
    Cook CD; Nickerson MD
    J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin-induced avoidance behavior in the terrestrial Gastropoda Megalobulimus abbreviatus: evidence for TRPV-1 signaling and opioid modulation in response to chemical noxious stimuli.
    Kalil-Gaspar P; Marcuzzo S; Rigon P; Molina CG; Achaval M
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Oct; 148(2):286-91. PubMed ID: 17553716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
    Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
    Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system.
    Sibilia V; Lattuada N; Rapetti D; Pagani F; Vincenza D; Bulgarelli I; Locatelli V; Guidobono F; Netti C
    Neuropharmacology; 2006 Sep; 51(3):497-505. PubMed ID: 16759671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.
    Slingsby LS; Murrell JC; Taylor PM
    Vet J; 2012 Jun; 192(3):523-4. PubMed ID: 22030474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
    Hernández-Delgadillo GP; Cruz SL
    Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of self-synergism in the antinociceptive effect of tramadol in rats.
    de Pozos-Guillén AJ; Aguirre-Bañuelos P; Arellano-Guerrero A; Hoyo-Vadillo C; Pérez-Urizar J
    Proc West Pharmacol Soc; 2004; 47():117-9. PubMed ID: 15633629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.